589 related articles for article (PubMed ID: 25200378)
21. Accuracy of classification of breast ultrasound findings based on criteria used for BI-RADS.
Heinig J; Witteler R; Schmitz R; Kiesel L; Steinhard J
Ultrasound Obstet Gynecol; 2008 Sep; 32(4):573-8. PubMed ID: 18421795
[TBL] [Abstract][Full Text] [Related]
22. BI-RADS 3, 4, and 5 lesions: value of US in management--follow-up and outcome.
Raza S; Chikarmane SA; Neilsen SS; Zorn LM; Birdwell RL
Radiology; 2008 Sep; 248(3):773-81. PubMed ID: 18647850
[TBL] [Abstract][Full Text] [Related]
23. Additional diagnostic value of MRI in patients with suspicious breast lesions based on ultrasound.
Sarica O; Uluc F
Br J Radiol; 2014 Sep; 87(1041):20140009. PubMed ID: 24983629
[TBL] [Abstract][Full Text] [Related]
24. The clinical impact of breast scintigraphy acquired with a breast specific γ-camera (BSGC) in the diagnosis of breast cancer: incremental value versus mammography.
Spanu A; Sanna D; Chessa F; Manca A; Cottu P; Fancellu A; Nuvoli S; Madeddu G
Int J Oncol; 2012 Aug; 41(2):483-9. PubMed ID: 22641247
[TBL] [Abstract][Full Text] [Related]
25. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
[TBL] [Abstract][Full Text] [Related]
26. Frequency of malignancy in lesions classified as probably benign after dynamic contrast-enhanced breast MRI examination.
Sadowski EA; Kelcz F
J Magn Reson Imaging; 2005 May; 21(5):556-64. PubMed ID: 15834907
[TBL] [Abstract][Full Text] [Related]
27. Positive predictive value of breast cancer in the lesions categorized as BI-RADS category 5.
Wiratkapun C; Lertsithichai P; Wibulpholprasert B
J Med Assoc Thai; 2006 Aug; 89(8):1253-9. PubMed ID: 17048437
[TBL] [Abstract][Full Text] [Related]
28. Nonpalpable BI-RADS 4 breast lesions: sonographic findings and pathology correlation.
Elverici E; Barça AN; Aktaş H; Özsoy A; Zengin B; Çavuşoğlu M; Araz L
Diagn Interv Radiol; 2015; 21(3):189-94. PubMed ID: 25835079
[TBL] [Abstract][Full Text] [Related]
29. Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS).
Badan GM; Piato S; Roveda D; de Faria Castro Fleury E
Eur J Radiol; 2016 Oct; 85(10):1701-1707. PubMed ID: 27666605
[TBL] [Abstract][Full Text] [Related]
30. False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study.
Baltzer PA; Benndorf M; Dietzel M; Gajda M; Runnebaum IB; Kaiser WA
AJR Am J Roentgenol; 2010 Jun; 194(6):1658-63. PubMed ID: 20489110
[TBL] [Abstract][Full Text] [Related]
31. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41.
Hooley RJ; Greenberg KL; Stackhouse RM; Geisel JL; Butler RS; Philpotts LE
Radiology; 2012 Oct; 265(1):59-69. PubMed ID: 22723501
[TBL] [Abstract][Full Text] [Related]
32. Characteristics and Outcomes of BI-RADS 3 Lesions on Breast MRI.
Panigrahi B; Harvey SC; Mullen LA; Falomo E; Di Carlo P; Lee B; Myers KS
Clin Breast Cancer; 2019 Feb; 19(1):e152-e159. PubMed ID: 30268764
[TBL] [Abstract][Full Text] [Related]
33. US and MRI in the evaluation of mammographic BI-RADS 4 and 5 microcalcifications.
Hrkac Pustahija A; Ivanac G; Brkljacic B
Diagn Interv Radiol; 2018 Jul; 24(4):187-194. PubMed ID: 30091708
[TBL] [Abstract][Full Text] [Related]
34. Frequency of Malignancy and Imaging Characteristics of Probably Benign Lesions Seen at Breast MRI.
Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
AJR Am J Roentgenol; 2015 Aug; 205(2):442-7. PubMed ID: 26204298
[TBL] [Abstract][Full Text] [Related]
35. The value of MRI for downgrading of breast suspicious lesions detected on ultrasound.
Xie Z; Xu W; Zhang H; Li L; An Y; Mao G
BMC Med Imaging; 2023 Jun; 23(1):72. PubMed ID: 37271827
[TBL] [Abstract][Full Text] [Related]
36. Breast magnetic resonance imaging as a problem-solving modality in mammographic BI-RADS 3 lesions.
Dorrius MD; Pijnappel RM; Jansen-van der Weide MC; Oudkerk M
Cancer Imaging; 2010 Oct; 10 Spec no A(1A):S54-8. PubMed ID: 20880790
[TBL] [Abstract][Full Text] [Related]
37. Role of magnetic resonance imaging in probably benign (BI-RADS category 3) microcalcifications of the breast.
Linda A; Zuiani C; Londero V; Di Gaetano E; Dal Col A; Girometti R; Bazzocchi M
Radiol Med; 2014 Jun; 119(6):393-9. PubMed ID: 24297595
[TBL] [Abstract][Full Text] [Related]
38. JOURNAL CLUB: Diagnostic Utility of MRI After Negative or Inconclusive Mammography for the Evaluation of Pathologic Nipple Discharge.
Bahl M; Gadd MA; Lehman CD
AJR Am J Roentgenol; 2017 Dec; 209(6):1404-1410. PubMed ID: 28898125
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of probably benign breast MRI lesions.
Eby PR; DeMartini WB; Gutierrez RL; Saini MH; Peacock S; Lehman CD
AJR Am J Roentgenol; 2009 Sep; 193(3):861-7. PubMed ID: 19696303
[TBL] [Abstract][Full Text] [Related]
40. Growing BI-RADS category 3 lesions on follow-up breast ultrasound: malignancy rates and worrisome features.
Ha SM; Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
Br J Radiol; 2018 Jul; 91(1087):20170787. PubMed ID: 29658793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]